PharmaEngine (4162) - Total Liabilities

Latest as of September 2025: NT$112.86 Million TWD ≈ $3.56 Million USD

Based on the latest financial reports, PharmaEngine (4162) has total liabilities worth NT$112.86 Million TWD (≈ $3.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PharmaEngine cash conversion from operations to assess how effectively this company generates cash.

PharmaEngine - Total Liabilities Trend (2009–2024)

This chart illustrates how PharmaEngine's total liabilities have evolved over time, based on quarterly financial data. Check PharmaEngine (4162) asset resilience to evaluate the company's liquid asset resilience ratio.

PharmaEngine Competitors by Total Liabilities

The table below lists competitors of PharmaEngine ranked by their total liabilities.

Company	Country	Total Liabilities
Innoprise Plantations Bhd KLSE:6262	Malaysia	RM98.25 Million
Export Inv TA:EXPO	Israel	ILA20.83 Billion
Kernex Microsystems (India) Limited NSE:KERNEX	India	Rs2.88 Billion
Oriental Precision & Engineering Co.Ltd KQ:014940	Korea	₩110.71 Billion
Ace Bed Company Limited KQ:003800	Korea	₩66.25 Billion
Launch Two Acquisition Corp. Class A Ordinary Shares NASDAQ:LPBB	USA	$11.11 Million
Falcon Oil & Gas Ltd. V:FO	Canada	CA$18.06 Million
Pennar Industries Limited NSE:PENIND	India	Rs22.62 Billion

Liability Composition Analysis (2009–2024)

This chart breaks down PharmaEngine's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PharmaEngine market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	43.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaEngine's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaEngine (2009–2024)

The table below shows the annual total liabilities of PharmaEngine from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$448.01 Million ≈ $14.11 Million	+392.29%
2023-12-31	NT$91.01 Million ≈ $2.87 Million	-3.66%
2022-12-31	NT$94.47 Million ≈ $2.98 Million	+7.71%
2021-12-31	NT$87.70 Million ≈ $2.76 Million	-55.20%
2020-12-31	NT$195.78 Million ≈ $6.17 Million	+22.06%
2019-12-31	NT$160.40 Million ≈ $5.05 Million	+5.06%
2018-12-31	NT$152.67 Million ≈ $4.81 Million	-23.63%
2017-12-31	NT$199.90 Million ≈ $6.30 Million	+24.56%
2016-12-31	NT$160.48 Million ≈ $5.06 Million	+102.09%
2015-12-31	NT$79.41 Million ≈ $2.50 Million	+340.73%
2014-12-31	NT$18.02 Million ≈ $567.67K	-30.44%
2013-12-31	NT$25.90 Million ≈ $816.09K	+82.39%
2012-12-31	NT$14.20 Million ≈ $447.44K	-8.90%
2011-12-31	NT$15.59 Million ≈ $491.17K	+12.60%
2010-12-31	NT$13.85 Million ≈ $436.19K	-54.60%
2009-12-31	NT$30.50 Million ≈ $960.76K	--

About PharmaEngine

TWO:4162 Taiwan Biotechnology

Market Cap

$245.05 Million

NT$7.78 Billion TWD

Market Cap Rank

#15764 Global

#712 in Taiwan

Share Price

NT$54.90

Change (1 day)

+0.37%

52-Week Range

NT$53.80 - NT$92.50

All Time High

NT$178.54